FI46955C - Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi - Google Patents

Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi

Info

Publication number
FI46955C
FI46955C FI16964A FI16964A FI46955C FI 46955 C FI46955 C FI 46955C FI 16964 A FI16964 A FI 16964A FI 16964 A FI16964 A FI 16964A FI 46955 C FI46955 C FI 46955C
Authority
FI
Finland
Prior art keywords
chlorobenzoyl
preparation
therapeutically active
indolylacetic acid
lower alkyl
Prior art date
Application number
FI16964A
Other languages
English (en)
Swedish (sv)
Other versions
FI46955B (fi
Inventor
George Gal
Sletzinger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of FI46955B publication Critical patent/FI46955B/fi
Publication of FI46955C publication Critical patent/FI46955C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/36Oxygen atoms in position 3, e.g. adrenochrome

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI16964A 1963-02-01 1964-01-29 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi FI46955C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25564263A 1963-02-01 1963-02-01

Publications (2)

Publication Number Publication Date
FI46955B FI46955B (fi) 1973-05-02
FI46955C true FI46955C (fi) 1973-08-10

Family

ID=22969254

Family Applications (9)

Application Number Title Priority Date Filing Date
FI16964A FI46955C (fi) 1963-02-01 1964-01-29 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
FI257370A FI47185C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-indoli-3-etanolin v almistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja anlgeet tinen vaikutus.
FI256870A FI47096C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen tert.-butyyliesterin valmistamiseksi.
FI702570A FI47097C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
FI257070A FI47097B (fi) 1963-02-01 1970-09-21
FI257170A FI47098C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus.
FI257270A FI47099C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyylietikkaha pon valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja an algeettinen vaikutus.
FI257570A FI47101C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen valmistamiseksi.
FI257470A FI47100C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.

Family Applications After (8)

Application Number Title Priority Date Filing Date
FI257370A FI47185C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-indoli-3-etanolin v almistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja anlgeet tinen vaikutus.
FI256870A FI47096C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen tert.-butyyliesterin valmistamiseksi.
FI702570A FI47097C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
FI257070A FI47097B (fi) 1963-02-01 1970-09-21
FI257170A FI47098C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus.
FI257270A FI47099C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyylietikkaha pon valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja an algeettinen vaikutus.
FI257570A FI47101C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen valmistamiseksi.
FI257470A FI47100C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.

Country Status (11)

Country Link
AT (1) AT277992B (fi)
BE (1) BE643268A (fi)
BR (1) BR6456479D0 (fi)
CH (16) CH557815A (fi)
DE (16) DE1695492A1 (fi)
DK (11) DK112238B (fi)
FI (9) FI46955C (fi)
FR (1) FR1559559A (fi)
GB (13) GB1050732A (fi)
NL (1) NL6400813A (fi)
SE (12) SE302463B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU163233B (fi) * 1970-07-31 1973-07-28
WO1989012436A1 (fr) * 1988-06-21 1989-12-28 Vita Zahnfabrik H. Rauter Gmbh & Co. Kg Masse ceramique dispersee
GB9518994D0 (en) * 1995-09-16 1995-11-15 Agrevo Uk Ltd Fungicides

Also Published As

Publication number Publication date
CH489495A (de) 1970-04-30
FI47100B (fi) 1973-05-31
GB1050734A (fi)
AT277992B (de) 1970-01-12
DK112238B (da) 1968-11-25
CH466283A (de) 1968-12-15
GB1050729A (fi)
SE307948B (fi) 1969-01-27
DE1695491A1 (de) 1971-04-15
CH466289A (de) 1968-12-15
DK112313B (da) 1968-12-02
DE1695484A1 (de) 1971-04-15
CH557815A (de) 1975-01-15
CH457436A (de) 1968-06-15
SE320367B (fi) 1970-02-09
FI47098C (fi) 1973-09-10
BR6456479D0 (pt) 1973-09-20
DE1695492A1 (de) 1971-04-01
BE643268A (fi) 1964-07-31
DK113501B (da) 1969-03-31
GB1050736A (fi)
DK111751B (da) 1968-10-07
GB1050731A (fi)
CH464203A (de) 1968-10-31
FI47101B (fi) 1973-05-31
SE320666B (fi) 1970-02-16
DE1770802A1 (de) 1972-02-17
GB1050739A (fi)
CH466290A (de) 1968-12-15
FI47096C (fi) 1973-09-10
DE1695485A1 (de) 1971-04-15
GB1050732A (fi)
GB1050733A (fi)
DE1695487A1 (de) 1970-10-01
NL6400813A (fi) 1964-08-03
DE1695486A1 (de) 1971-04-15
SE302132B (sv) 1968-07-08
CH457435A (de) 1968-06-15
FI47099B (fi) 1973-05-31
CH466288A (de) 1968-12-15
DE1695490A1 (de) 1971-04-15
FI47096B (fi) 1973-05-31
FR1559559A (fi) 1969-03-14
DK109334C (da) 1968-04-16
CH457437A (de) 1968-06-15
DK112314B (da) 1968-12-02
CH466285A (de) 1968-12-15
FI47100C (fi) 1973-09-10
DK112239B (da) 1968-11-25
GB1050737A (fi)
CH457434A (de) 1968-06-15
DE1695489A1 (de) 1970-08-13
SE304995B (fi) 1968-10-14
FI47099C (fi) 1973-09-10
GB1050740A (fi)
DE1793561A1 (de) 1972-01-20
DE1770134A1 (de) 1971-09-30
CH466286A (de) 1968-12-15
FI47101C (fi) 1973-09-10
FI47185C (fi) 1973-10-10
FI47098B (fi) 1973-05-31
SE302133B (sv) 1968-07-08
FI47097C (fi) 1973-09-10
FI47097B (fi) 1973-05-31
SE302131B (fi) 1968-07-08
DE1770116A1 (de) 1971-10-14
DE1695488A1 (de) 1970-09-17
DK112446B (da) 1968-12-16
SE307133B (fi) 1968-12-23
SE302463B (fi) 1968-07-22
SE320069B (fi) 1970-02-02
GB1050728A (fi)
GB1050730A (fi)
DK109562C (da) 1968-05-13
DE1695493A1 (de) 1971-04-01
CH464202A (de) 1968-10-31
CH466284A (de) 1968-12-15
GB1050735A (fi)
FI46955B (fi) 1973-05-02
DK109514C (da) 1968-05-06
SE302130B (sv) 1968-07-08
GB1050738A (fi)
DE1470059B1 (de) 1970-01-29
SE317975B (fi) 1969-12-01
DK112447B (da) 1968-12-16
CH466287A (de) 1968-12-15
DE1770132A1 (de) 1971-09-30
FI47185B (fi) 1973-07-02

Similar Documents

Publication Publication Date Title
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
FI42564C (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia 2-aryyliamino-1,3-diatsasykloalkeeneja
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
CH487171A (de) Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine
DK133372B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf.
CH451146A (fr) Procédé de préparation de nouvelles amidines
FI41965C (fi) Menetelmä uusien terapeuttisesti vaikuttavien diaralkyyliamiinien valmistamiseksi
FI41394C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen I-aminoindaani-johdannaisten valmistamiseksi
NL140236B (nl) Werkwijze ter bereiding van farmacologisch werkzame sulfamylantranilzuurderivaten.
FI47881C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyyliasetamidi en valmistamiseksi
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI46955C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
NL145542B (nl) Werkwijze ter bereiding van therapeutisch werkzame carbaminezuurderivaten.
FI43994C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener.
FI43997C (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliinijohdannaisten valmistamiseksi
FI42093C (fi) Menetelmä salisyylihappo-johdannaisten valmistamiseksi
FI47880C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyylietikkahap pojen valmistamiseksi
FI43185C (fi) Menetelmä terapeuttisesti vaikuttavien 3,4-diklooribentseenisulfonihappo-3,4-substituoitu-anilidien valmistamiseksi
FI44408C (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliinijohdannaisten valmistamiseksi
FI43312C (fi) Menetelmä trans-4-aminometyylisykloheksaani-1-karbonihapon valmistamiseksi
FI42434C (fi) Menetelmä uusien, terapeuttisesti aktiivisten alfa-fenyylipropionihappo-johdannaisten valmistamiseksi
FI40636C (fi) Menetelmä terapeuttisesti vaikuttavien, alifaattisten hydroksidiaminien valmistamiseksi
FI43992C (fi) Valmistusmenetelmä uusille terapeuttisesti käytettäville 1-dialkyyliaminoalkyyli-4-okso-1,2,3,4-tetrahydrokinatsoliineille sekä niiden happoadditiosuoloille
BE627240A (nl) Werkwijze ter bereiding van therapeutisch werkzame stikstof-verbindingen